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Abstract 
 
Luciferase from the North American firefly Photinus Pyralis catalyzes a highly 
efficient bioluminescent reaction that produces yellow-green light (557 nm at pH 7.8). 
This bioluminescence system has been adapted for a variety of applications including 
gene reporter assays, detection of bacteria and toxins, whole-cell biosensor measurements, 
and in vivo imaging. A luciferase variant with a red-shifted bioluminescence spectra and 
high specific activity, two qualities that are challenging to achieve simultaneously, would 
be especially useful when paired with a green-emitting enzyme in a dual-color reporter 
assay, or used alone for improved imaging in living animals.  
Our lab previously reported a red-emitting mutant named Ppy RE, which 
contained a single mutation at S284T that shifted the emission maximum from the 557 
nm to 615 nm at pH 7.8. In a subsequent publication, Ppy RE was enhanced with five 
mutations to make Ppy RE-TS, which exhibited improved thermostability at 37°C, but at 
the expense of reducing the red-shift to 610 nm. In this report, we further improve upon 
Ppy RE-TS with four rational point mutations that red-shift the emission maximum to 
617 nm, dramatically increase the enzyme thermostability, and improve the total light 
emission during 8-second assays. This new enzyme, named PRET7, is characterized and 
evaluated for performance in E. Coli and HEK293 mammalian cell lines. Compared to a 
commercially available enzyme called CBR, which has been codon-optimized for 
expression in mammalian cells, PRET7 produces a stronger signal over 8-second assays 
in which the least expensive reagents available are used. Aiming to improve the already 
impressive performance of PRET7, we are currently awaiting results from collaborators 
who are evaluating a human codon-optimized version of PRET7 in HEK293 cells.  
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Introduction 
The North American firefly Photinus pyralis, known for its flash of yellow-green 
light, houses one of the most efficient bioluminescent systems ever studied1 (Fig. 1). The 
light-producing reaction is catalyzed by the luciferase enzyme (Luc)2, a ~62 kDa 
oxygenase that has been well-characterized (1, 2).  To begin the reaction, Luc adenylates 
the substrate firefly luciferin (LH2), a heterocyclic carboxylic acid, with Mg-ATP  
(Eq (1)).  The resultant luciferyl adenylate combines with molecular oxygen at the 
luciferase active site to produce an electronically excited state product (Eq. (2)). Upon 
relaxation to the ground state, a photon of visible light is emitted (Eq (3)).  
                                                         
                                                         Mg2+ 
Luc + LH2 + ATP  Luc•LH2-AMP + PPi  (1) 
 
Luc•LH2-AMP + O2 → Luc•AMP•Oxyluciferin* + CO2 (2) 
 
Luc•AMP•Oxyluciferin*→Luc + Oxyluciferin + AMP  + hν (3) 
   
 
This bioluminescence system has a quantum yield of 41.0 ± 7.4% (3), which is 
impressive compared to most chemiluminescent reactions (4). Also, unlike fluorescence 
systems, it does not require an external light source for excitation, and there is virtually 
                                                 
1
 This thesis research was presented at the National Conference for Undergraduate Research at the University of 
Wisconsin-La Crosse, on April 17, 2009. 
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 Abbreviations used: Luc, photinus pyralis luciferase; LH2, D-firefly luciferin; Ppy WT, recombinant photinus pyralis 
luciferase containing the additional N-terminal peptide GlyProLeuGlySer; Ppy RE, Ppy WT containing S284T; Ppy 
GR, Ppy WT containing V24I/G246A/F250S; Ppy RE-TS, Ppy RE containing T214A/A215L/I232A/F295L/E354K; 
Ppy GR-TS, Ppy GR containing T214A/A215L/I232A/F295L/E354K; PRET7, Ppy RE-TS containing 
R330G/I351V/K354E/ F465R; MAR, minimal assay reagents of 400 µM LH2, 2 mM Mg-ATP, and 25 mM 
glycylglycine buffer (pH 7.8); LAR, Promega’s luciferase assay reagent;
 
  BSA, bovine serum albumin; CB, 50 mM 
Tris-HCl (pH 7.0) containing 150 mM NaCl, 1 mM EDTA, and 1 mM dithiothreitol; CBA, CB with 0.8 M ammonium 
sulfate and 2% glycerol; EDTA, ethylenediaminetetraacetic acid;  IPTG, 100 mM isopropyl-β-d-thiogalactopyranoside; 
LB-amp, Luria Bertani broth with 100µg/ml  ampicillin; PBS, phosphate-buffered saline; PMT, photomultiplier tube. 
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no non-specific light production induced in the cellular environment. As such, it is 
possible to detect even trace amounts of luciferase using photomultiplier tubes (PMTs) or 
charge-coupled devices (CCDs). It has been estimated that attomole levels of luciferase 
can be quantified (5), making the enzyme an attractive candidate for bioanalytical uses 
where high sensitivity is desired. Among a vast variety of applications, firefly luciferase 
has been used in probes for detecting bacteria and environmental toxins(6), 
bioluminescence resonance energy transfer (BRET) assays to detect protein-protein 
interactions(7), whole-cell based biosensors(8), in vivo bioluminescence imaging(4,9), 
and gene expression assays(10, 11).   
 Many gene expression assays require two 
reporters, with one functioning as a control to monitor 
nonspecific interferences. For these assays it is 
necessary to employ two luminescent signals with 
spectral bandwidths that are easily separable by optical 
filters (12). Several commercial options are available 
for bioluminescent dual-analyte assays. The 
Promega Dual-Luciferase Reporter Assay System utilizes 
monitors two distinct bioluminescent reactions from firefly and Renilla luciferases, which 
are carried out sequentially using two different substrates and a stop solution. More 
elegant reporter systems require only one substrate to initiate multiple reactions 
simultaneously. A dual-color system based on Phrixothrix railroad worms (13, 14), and a 
tricolor enzyme system derived from Japanese beetle and railroad worm enzymes (15) 
Figure 1. North American firefly 
photinus pyralis with flashing lantern. 
(http://static.howstuffworks.com/gif/firefly.jpg) 
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both use only D-luciferin as a substrate, but may not be adequately sensitive for 
demanding assays. 
A drawback of both the above assay methods is that they require co-expression of 
dissimilar proteins. It has been shown that assays that combine luciferases of different 
species, like click beetle and firefly luciferases, can be ineffective because of differences 
in expression and in specific activity (12). The Promega Chroma-Lucvectors, which use 
a single reagent called Chroma-Glo, encode red- and green-emitting luciferase mutants 
from a single species, the Jamaican click beetle Pyrophorus plagiophthalamus(16). The 
reporter vectors included with this system are called CBR, CBG99, and CBG68, all of 
which are structurally and chemically alike. 
Our laboratory has already published two sets of red- and green-emitting firefly 
luciferase mutants to be used in dual-color assays. The first two mutants developed were 
named Ppy RE and Ppy GR (17). Ppy RE contained the single point mutation Ser284Thr, 
which had been discovered by random mutagenesis and which shifted the 
bioluminescence maximum from 557 nm to 615 nm at pH 7.8. Ppy GR, originally 
designed for a different project, contained the mutations 
Val241Ile/Gly246Ala/Phe250Ser, and was effectively blue-shifted to 549 nm. 
Considering the 66 nm difference in the emission maxima of these enzymes, as well as 
the sufficiently narrow bandwidths of the bioluminescence curves, we predicted minimal 
spectral overlap if the two enzymes were to be used simultaneously (Fig. 2).  
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Indeed, model experiments showed that the red and green signals could be 
separated by optical filters, such that the enzymes were distinguishable from one another 
at femtomolar quantities. But Ppy RE and GR, like wild-type firefly luciferase, required 
refrigeration to remain active. At 37°C, the activity of Ppy GR dropped to 50% in under 
15 minutes and Ppy RE dropped to 50% in under an hour.  Concerned that these enzymes 
might have limited utility in experiments conducted at physiological or even just room 
temperature, we created thermostable versions named Ppy RE-TS and Ppy GR-TS (18).  
The same five mutations were added to both Ppy RE and GR to increase their 
stability at 37°C: Thr214Ala, Ala215Leu, Ile232Ala, Phe295Leu, and Glu354Lys. These 
mutations were discovered in the lab of L.C. Tisi, who introduced them into wild-type 
firefly luciferase and reported a significant increase in thermostability (19, 20). After 
Figure 2. Normalized bioluminescence emission spectra produced by the 
Ppy GR and Ppy RE luciferases at pH 7.8, obtained as previously reported (17). 
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mutating our enzymes, Ppy GR-TS exhibited a 46-fold increase in thermostability, and 
Ppy RE-TS increased 7-fold. But the additional mutations also had the undesired effect of 
shifting the bioluminescence spectra of both the enzymes. Though the green-emitter 
became slightly greener, shifted from 548 to 546 nm, the red-emitter dropped from 615 to 
610 nm, creating more overlap between the two bioluminescence curves.   
The work presented here is our third attempt to engineer firefly luciferases 
suitable for dual-color applications. Having already improved on enzyme thermostability, 
we aimed to improve on the separation between the red and green bioluminescence 
curves. The bioluminescence profile of the green-emitter has a tail that encroaches on the 
red area of the spectrum, and cannot be eliminated by modifying the enzyme. As such, 
we chose to modify Ppy RE-TS alone, aiming to further red-shift its bioluminescence 
spectrum. Mutations that cause red-shifts in luciferases often compromise the specific 
activity of the enzyme. For example, Ppy RE-TS exhibits a flash-height based specific 
activity only 23% of P. pyralis wild-type luciferase (Ppy WT). We hoped to rationally 
incorporate point mutations into Ppy RE-TS to achieve a redder-emitting enzyme while 
retaining or improving its specific activity, favorable kinetic properties, and 
thermostability.  
Our lab has developed a new red-emitting mutant, PRET7, which is 7 nm  
red-shifted compared to the precursor Ppy RE-TS, has improved specific activity and 
exhibits prolonged stability at 37°C. The pure protein was characterized and compared to 
Promega’s red-emitting commercial enzyme CBR, a click beetle luciferase that has been 
codon-optimized for expression in mammalian cells. To predict the performance of the 
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PRET7 and CBR in reporter assays, luciferase-expressing E. Coli and mammalian 
HEK293 cells were lysed and assayed for luminescence. To complete the study, a  
codon-optimized variant of PRET7 was designed, and at the time of this writing is being 
tested in HEK293 cells by collaborators at Promega. Here we present evidence for 
possible advantages and disadvantages of using PRET7, as compared to CBR, for 
bioanalytical applications.  
 
Materials and Methods 
 
Materials. The following materials were obtained from the sources indicated:  
Bacterial Mg-ATP and GenElute DNA Miniprep Kit from Sigma-Aldrich (St. Louis, 
MO); restriction endonucleases from New England Biolabs (Beverly, MA); mutagenic 
oligonucleotides from Invitrogen and Integrated DNA Technologies (Carlsbad, CA and 
Coralville, IA); Glutathione Sepharose 4B media and pGEX-6P-2 expression vector from 
GE Healthcare (Piscataway, NJ); QuikChange Site-Directed Mutagenesis kit from 
Stratagene (La Jolla, CA); QIAquick PCR purification kit and QIAquick gel extraction 
kit from Qiagen (Valencia, CA); DMEM and Opti-MEM® I reduced-serum medium 
from Invitrogen (Carlsbad. CA); 10% FBS from Thermo Scientific Hyclone (Logan, 
UT); TransIT®-LTI transfection reagent from Mirus Bio (Madison, WI); D-Firefly 
luciferin, the pCBR-Basic Vector, Luciferase Assay Reagent (LAR), were generous gifts 
from Promega (Madison, WI). The Passive Lysis Buffer and Flexi® Vector pF9a were 
provided by Promega as well.  
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General Methods. Luciferase genes in the pGEX-6p-2 vector were altered by 
 site-directed mutagenesis (described below) and transformed into E. Coli XL10 gold 
cells. Luciferase-expressing clones were selected by a dark-room screening and the 
plasmid was retrieved using Sigma’s GeneElute DNA Miniprep Kit. Mutations were 
confirmed by DNA sequencing at the W.M. Keck Biotechnology Laboratory at Yale 
University. 
After transformation into E. Coli BL21 cells, the proteins were expressed at 
22 °C and purified by a method described below. Mass-shifts of pure proteins were 
verified by tandem HPLC-electrospray ionization mass spectrometry with a 
ThermoFinnigan Surveyor HPLC system and a ThermoFinnigan LCQ Advantage mass 
spectrometer.  The found molecular masses (Da) of the proteins were: CBR, 60 596 and 
Ppy PRET7 (Ppy RE TS/Arg330Gly/ Ile351Val/ Lys354Glu/ Phe465Arg), 61 000. The 
determined mass values were all within the allowable experimental error (0.01 %) of the 
calculated values. The concentrations of pure protein solutions were determined with the 
Biorad Protein Assay system, using BSA as the standard. The recombinant Ppy WT,  
Ppy RE and Ppy RE-TS proteins were expressed and purified as previously reported (17, 
18, 21). 
 
Site-directed mutagenesis. Starting with the designated DNA sequences in the 
pGEX-6P-2 vector as templates, the QuikChange Site-Directed Mutagenesis kit was 
used to create the PRET7 mutant from the Ppy RE-TS template.  These primers and their 
respective reverse complements were used: Arg330Gly5´ - G GTT GCA AAA GGC 
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TTC CAT CTT CCA GGG ATA CGC CAA GGA TAT G- 3´ [StyI]; 
Ile351Val/Lys354Glu, 5´ - GAG ACT ACT AGC GCT ATT CTG GTA ACA CCC 
GAG GGG GAT GAT AAA C- 3´ [SpeI]; Phe465Arg, 5´ - GAA TTG GAA TCC ATA 
TTG TTA CAA CAC CCC AAC ATC CGG GAC GCG GGC- 3´ [ClaI] (bold 
represents the mutated codon, underline represents silent changes to create a unique 
screening endonuclease site and brackets indicate the screening endonuclease).  
 
Insertion of Promega’s CBRluc into the pGEX-6P-2 vector.  The following 
primer set was used to amplify CBRluc from Promega’s pCBR-Basic: 5´- GGT AAA 
GGA TCC ATG GTA AAG CGT GAG AAA AAT GTC-3´ [BamHI] and 5´-ACT CAT 
CTC GAG ATC TTA TCA TGT CTG CTC GAA G-3´ [XhoI] (underline represents 
endonuclease site introduced for cloning into the pGEX-6P-2 vector and brackets indicate 
the endonuclease). PCR amplification conditions were: initial denaturation at 95°C for  
2 min, amplification for 30 cycles (each cycle was 95 °C for 30s, 55 °C for 30s and 68 °C 
for 1.75 min) and a final extension at 68 °C for 5 min. PCR products were cleaned with 
the QIAquick PCR purification kit and then digested with the restriction endonucleases 
listed above. Digested products were purified from an agarose gel with the QIAquick gel 
extraction kit and ligated into the corresponding sites on the pGEX-6P-2 vector. 
 
Protein expression and purification. Luciferases were expressed as GST-fusion 
proteins in E. Coli strain BL21 at 22°C for 18-20 hours in a 500ml culture with LB-amp 
media. The cells were harvested by centrifugation at 4°C and the pellets were frozen at  
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-80°C for at least 15 minutes. They were resuspended in 50 ml of phosphate-buffered 
saline (PBS) containing 0.1 mM phenylmethylsulfonyl fluoride. Cell membranes were 
weakened with the addition of a lysozyme solution (5 ml of 10 mg/ml lysozyme in PBS) 
and lysed by sonication. To solubilize membrane components, Triton X-100 (1% final 
volume) was added. Whole cell extracts were isolated by centrifugation at 20,000×g for 
45 minutes at 4°C.  
Proteins were further purified using glutathione Sepharose4B affinity 
chromatography according to the manufacturer’s instructions.  During this purification, 
luciferases were released from the GST tags by incubation in Prescission protease in CB 
(50 mM Tris-HCl (pH 7.0) containing 150 mM NaCl, 1 mM EDTA, and 1 mM 
dithiothreitol) for 18-20 hours at 4°C with gentle mixing. Proteins were eluted with CB 
and were stored at 4°C in this buffer with additives 0.8 M ammonium sulfate and  
2% glycerol (CBA).  
For studies in bacterial lysates, the GST-luciferase fusion proteins were 
expressed in E. coli strain BL21, grown in 10 ml LB-amp at 37 °C to mid log phase 
(A600 = 0.6-0.9) and induced with 0.1 mM IPTG.  Following expression for 16 hrs at 
37 °C, the cells were harvested by centrifugation at 4 °C and the resulting pellets were 
resuspended in 0.5 ml of PBS containing 0.1 mM PMSF and 0.5 mM DTT.  Lysozyme 
(5 µl of a 10 mg/ml solution) was added to the cell suspensions and they were incubated 
on ice for 10 minutes. The cell suspensions were then frozen in a dry ice-isopropanol bath 
and rapidly thawed in a 37°C water bath.  After 10 additional freeze/thaw cycles, the 
lysates were treated with DNase (5 µg/ml) and RNase (10 µg/ml) for 5 min on ice. Triton 
X-100 (1% final volume) was added and the soluble cell lysates were isolated by 
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centrifugation at 13,000×g for 30 min at 4°C. These extracts were assayed within several 
hours of isolation, and could not be stored with additives as the pure proteins were.   
 
 
Bioluminscence activity-based light assays. A description of the equipment used 
to perform bioluminescence activity-based light assays has been published previously(22). 
Reactions were carried out in polypropylene tubes that contained 2-3 µl pure luciferase in 
CBA and 400 µl LH2 in glycylglycine buffer (pH 7.8). A final assay concentration 70 µM 
LH2 was adequate for all luciferase mutants except for PRET7, which required 300 µM 
LH2 due to its elevated Km constant. Reactions were initiated by injecting 120µl of  
Mg-ATP (in glycylglycine buffer, pH 8.0, final concentration 2.0 mM) for a total assay 
volume of 522-523 µl. A Hamamatsu R928 PMT was used to measured specific activity 
based on flash height, as well as integrated activities based on light emission over  
15-minute intervals, and corrections were applied for the spectral response of the PMT 
(Table 1). 
 
Heat inactivation studies. Pure luciferases in CBA were diluted to 0.08-0.10 
mg/ml, transferred to thin-walled PCR tubes and incubated at 37°C in a thermocycler 
without heating the lid. Bioluminescence activity-based light assays were performed in 
duplicate to track enzyme inactivation. Control samples were kept at 4°C and did not 
drop below 90% activity throughout the assays. Enzymes were tested until a 50% activity 
loss was observed, with the exception of PRET7 and Ppy RE-TS (Table 1). After 24 
hours of incubation, PRET7 did not drop below 50% activity, so a value of >24 hours 
was reported. The 8.8 hour value for Ppy RE-TS was extrapolated from data points taken 
up to two hours. 
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Bioluminescence emission spectra. Bioluminescence emission spectra for 
luciferases were obtained at 25°C and 37°C in a Perkin-Elmer LS55 luminescence 
spectrometer with the excitation source turned off, using previously described software 
and methods (22). Reactions contained 20 µl CBA, 120 µl Mg-ATP(2.0 mM), 70 µl LH2, 
and a reaction buffer for a 525µl total assay volume upon the addition of 5 µl luciferase to 
the cuvette. The reaction buffers used to vary pH were 25 mM Mes (pH 6.0), 25 mM 
glycylglycine (pH 7.0 and 7.8), and 50 mM Tris (pH 8.6). The spectra at 37 °C were 
obtained 30 min after the addition of the luciferase to the buffered reagent solutions 
maintained at 37 °C. To ensure that the spectra were not shifting during measurement, 
reactions were allowed to proceed for at least one minute before the spectra were 
measured. Results were corrected for the spectral response of the R298 photomultiplier 
tube.  
 
Microplate luminometer assays. A Luminoskan Ascent Microplate Luminometer 
(Thermo Fisher Scientific, Waltham, MA) was used to measure the light emission from 
PRET7 and CBR pure protein samples, and from GST-proteins expressed at 37°C in  
E. Coli and extracted as soluble cell lysates. Measurements were performed in triplicate 
in 96-well plates (LUMITRAC). In studies using minimal assay reagents (MAR), each 
well contained 2 µl of sample in 200 µl LH2 in 25 mM glycylglycine buffer (pH 7.8). For 
wild-type controls and CBR samples, 91 µM LH2 was used to saturate the enzyme. For 
PRET7, 400 µM LH2 was needed. Assays were initiated by injection of 60 µl Mg-ATP 
(9mM) in the same buffer. Light output was measured immediately and integrated using 
the monitor measurement function with an integration time of 20 ms and a measurement 
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count of 200. For assays in which the initial flash was not needed, a lag time of 2s was 
used.  Data were collected using a PMT voltage of 300 and a 635 nm long-pass filter in 
place. The data were scaled by 100 and no corrections were applied for the spectral 
response of the PMT.  
Similar activity assays were also performed using Promega’s Luciferase Assay 
Reagent (LAR).  Each assay consisted of 2 µl sample in 130 µl of 25 mM glycylglycine 
buffer (pH 7.8) and assays were initiated by injection of 130 µl of LAR. For the LAR 
assay using bacterial lysates, an additional luminometric measurement with an integration 
time of 5000 ms preceded the usual measurement with 20 ms integration. This 
programming change altered the relative light units reported by the Ascent software, 
which explains the difference in the y-axis values plotted in Figure 6.  
To find detection limit assays of purified proteins, stock solutions were prepared 
by diluting all proteins to 0.65 mg/ml using CBA containing 1mg/ml BSA.  The stock 
solutions were serially diluted and 2 µl (2.1 amol– 4.3pmol) aliquots were assayed as 
above, using a lag time of 2s and a PMT voltage of 900. The values obtained were 
corrected for background bioluminescence and plotted. Detection limits were defined as a 
S/N (signal:noise) ratio greater than or equal to 2.0.  
 
Mammalian cell experiments by Promega collaborators. Promega technicians 
cloned luciferase genes into the Flexi® Vector pF9a CMV mammalian expression vector. 
Incorporation into the vector was confirmed by sequencing at Agencourt Bioscience 
Corporation (Beverly, MA).  
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Transfection of mammalian cells with Luc mutants.  HEK293 (ATCC) cells were 
transfected with luciferase genes in the Flexi® Vector pF9a CMV mammalian expression 
vector as follows. HEK293 cells were plated into 6 well plates at a concentration of 
~500,000 cells per well in DMEM + 10% FBS. Cells were allowed to recover overnight 
at 37 °C in 5% CO2.  For each well of mammalian cells to be transiently transfected,  
95 ul Opti-MEM® I reduced-serum medium was combined with 6 ul TransIT®-LTI 
transfection reagent. The mixture was then vortexed at the highest setting for 1 s and 
incubated for 20 min at ambient temperature. Next, 2 ug of plasmid DNA was added to 
the Opti-MEM® I + TransIT®-LTI solution. The mixture was incubated at ambient 
temperature for 20 min, then added to the mammalian cells. Transfections were allowed 
to proceed for roughly 20 hr at 37 °C in the presence of 5% CO2.  
 
Preparation of soluble cell lysates from HEK293 cells expressed at 37 °C. 
Following transfection, HEK293 cells (600,000 cells) were harvested by trypsinization 
and pelleted by centrifugation at 1000 rpm for 5 minutes. The mammalian cell pellets 
were then resuspended in 500 µl PBS. Cell lysis was carried out by subjecting the 
resuspended cells to 5 freeze-thaw cycles at -80 °C and 30 °C. The cell lysates were 
finally treated with 1% Triton X-100.  
 
Bioluminescence in mammalian cells. Luminescence measurements of soluble 
cell lysates from HEK293 mammalian cells were performed in triplicate in 96-well tissue 
culture plates (Costar) using a Varioskan Flash spectral scan multimode plate reader 
(Thermo Fisher Scientific, Waltham, MA) programmed with SkanIT Software version 
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2.4.  For studies using MAR, each well contained 10 ul of soluble cell lysate in 200 ul of 
300 uM LH2 in 25 mM glycylglycine buffer (pH 7.8). Assays were initiated by injection 
of 60 ul Mg-ATP (2mM) in 25 mM glycylglycine buffer (pH 7.8). Using the kinetic 
measurement function, light output was measured immediately and integrated at 
500 ms/measurement with each sample being measured continuously for 30 
measurements. Light output was measured using a PMT voltage that was automatically 
adjusted using the AutoRange default setting and filtered through a 600 nm long-pass 
filter.  The Varioskan Flash spectral scan multimode plate reader has a built in delay of 
0.8s before the first data point is recorded. No corrections were applied for the spectral 
response of the PMT.   
 Bioluminescence activity assays were also performed using LAR. For these 
experiments, the trypsinized transfected mammalian cells were plated in 96 well plates at 
20,000 cells per well and allowed to recover overnight at 37 °C in the presence of 5% 
CO2. The media was removed and 20ul 1x Passive Lysis Buffer was added to each well 
and the cells were allowed to lyse for 10 min while shaking at 500 rpm. Following the 
cell lysis, plates were placed into the Varioskan Flash plate reader and the reaction was 
initiated by auto injection of 100ul LAR. Measurements were made as described above.  
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Results and Discussion 
 
Rationale for mutagenesis. Using Ppy RE-TS as a template that was already 
characterized (18), we logically introduced point mutations into the gene with the 
intention of creating a further red-shifted mutant. In the course of a different project in 
our lab, the mutation Arg330Gly, discovered by a random mutagenesis screening, was 
found to produce a 9 nm red-shift in other mutants. When introduced into Ppy RE-TS, the 
mutation shifted its bioluminescence an additional 4 nm, resulting in maximum emission 
at 614 nm. However, we observed a two-fold decrease in the protein yield from cultures 
grown at 37°C, and in the longevity of the protein activity when incubated at 37°C, 
indicating that Arg330Gly had decreased the thermostability of the enzyme. To remedy 
this problem, we altered residue Phe465, which was identified in L.C. Tisi’s lab as yet 
another residue important to thermostability (19, 20). After mutating this residue to an 
Arg, the protein yield at 37 °C increased 3.5-fold (a 1.6-fold improvement over  
Ppy RE-TS), while the bioluminescence color dropped to 613 nm.  
Hoping to compensate for the 1 nm loss in the red-shift, we chose to modify one 
of the five thermostablity mutations that had been adapted from Tisi’s work to engineer 
Ppy RE-TS. Of these mutations, Glu354Lys was seen to cause a 6-nm blue-shift in the 
bioluminescence emission spectrum (data not published), so it was reverted with the aim 
of regaining red color. Reverting the Lys354 to the native Glu residue caused a promising 
4 nm red-shift in the bioluminescence emission maxima, resulting in a mutant with a λmax 
of 617 nm.  
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The final mutation, Ile351Val, had been observed previously by our lab to 
increase the integrated specific activity of Ppy WT 1.2-fold (data not published) while not 
affecting the color of Luc wild-type.  When introduced into the red-emitting mutant, the 
8-second integrated specific activity surpassed that of the Ppy RE-TS template. All 
mutations and reversions accounted for, this resultant enzyme could be identified as 
Ppy WT with eight changes: T214A, A215L, I232A, S284T, R330G, I351V, F465R, and 
F295L (Fig. 3). It can alternately be viewed as Ppy RE with seven changes,   
 and was therefore named PRET7 (Ppy, Red-emitter, Thermostable, 7 mutations).   
 
 
Figure 3. Eight mutations added to wild-type P. Pyralis firefly luciferase to create red-emitting 
mutant PRET7. 
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Bioluminescence color of luciferase mutants. The new red-emitting mutant PRET7 
was characterized and compared with both previous templates, Ppy RE and Ppy RE-TS, as 
well as Promega’s commercial enzyme CBR. Improved bioluminescence color had been the 
primary goal in engineering PRET7, and this goal was met. When the five thermostability 
mutations were added to Ppy RE to make Ppy RE-TS, a slight green-shift occurred at both 
25°C and 37°C, resulting in emission maxima of 610 nm and 612 nm, respectively (Table 1). 
The four alterations in PRET7 caused red-shifts at both assayed temperatures, resulting in 
emission maxima at 617 nm and 618 nm. Therefore, the impressive 615 nm maximum of  
Ppy RE was not only restored, but also exceeded by PRET7 (Fig. 6). Also, the PRET7 
emission maximum matches that of CBR at 25°C and is only one nm lower at 37°C. At both 
temperatures, PRET7 has a slightly smaller bandwidth at full-width half-maximum than CBR, 
indicating a more narrow emission profile, which is necessary to minimize spectral overlap 
with a green counterpart in dual-analyte assays.  
The improved red-shift of PRET7 might also make it a good candidate for in vivo 
bioluminescence imaging. The expression of bioluminescent proteins inside live mammals 
can be used to visualize events such as tumor growth and metastasis, cell trafficking, 
apoptosis, and to confirm gene delivery (23, 24, 25). One challenge in these applications is 
the scattering and absorption of light due to hemoglobin and myoglobin (23). Because light 
of 600 nm or longer wavelength penetrates tissue better than do shorter wavelengths (23), 
PRET7 should be well-suited for in vivo imaging. To investigate its potential as an imaging 
reporter, PRET7 has been sent to the lab of Aldo G. Roda (University of Bologna, Italy), 
where it is currently being evaluated in murine models.  
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  Figure 4. Bioluminescence spectra of Ppy WT (green curve), Ppy RE-TS (orange curve)  
  and PRET7 (red curve) were obtained at pH 7.8 and 25°C using a Perkin-Elmer LS55 
  luminescence spectrometer with the excitation source turned off, as described in 
  Materials and Methods. 
 
 
Specific activities of luciferase mutants. Red-shifted bioluminescence is often 
difficult to achieve without incurring losses in the flash-height based specific activity of 
the luciferase. For example, Ppy RE, which contains only the single S284T mutation, lost 
77% of its flash-height based specific activity relative to Ppy WT (Table 1). As 
anticipated, the flash-height specific activity of PRET7 dropped relative to Ppy RE-TS. 
But this activity loss was not too dramatic, considering that PRET7 is still over 7-fold 
more active than CBR in terms of flash-height.  
For dual-analyte assays that are carried out for several seconds or minutes, the 
sustained light-emission of the luciferase may be more important than the initial flash. 
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Unlike the case with flash-height, mutations to red-shift a luciferase do not necessarily 
have predictable effects on the sustained light emission of an enzyme. When light output 
was integrated over 8-second and 15-minute intervals, PRET7 appeared to have 
respectively gained and lost specific activity compared to Ppy RE-TS. But more 
importantly, the advantage over CBR was not lost, since PRET7 emits ~7-fold more light  
than CBR in the 8s assay, and ~9-fold more light in the 15-minute assay. In summary, 
our objective of making PRET7 red-shifted without significantly compromising specific 
activity was achieved. PRET7, like Ppy RE-TS, provides a stronger signal during the 
initial flash and throughout 8-second and 15-minute assays compared to commercially 
available CBR.  
 
 
 
 
 Table 1. Properties of pure luciferases at pH 7.8 
 
a 
 Characterization of Ppy RE and Ppy RE-TS was previously reported (17, 18).  
 
b
 Flash height-based and 15 min integrated specific activities were obtained as described in Materials and Methods and 
were corrected for the spectral response of the Hamamatsu R928 PMT.  Enzyme activity values used to calculate 8s 
integration values were obtained as described in Materials and methods using a Luminoskan microplate luminometer to 
integrate light output for 8 sec after a 2-sec delay, employing a 610 nm cut-off filter. All activity values are expressed 
relative to Ppy WT at pH 7.8, defined as 100.   
c Bioluminescence emission  spectra of purified proteins were obtained as described in Materials and methods, with 
bandwidths at full-width half-maximum (fwhm) and shoulders (sh) indicated. 
 
 
 
 
 
Enzyme 
 
Relative specific activityb Thermal inactivation Bioluminescence emission 
maximumc 
Time to 50% activity loss, 
37 °C  (h) 
 Flash 
Height 
Integration  
(8s) 
 
Integration 
(15 min) 
 
25 °C 
λ max (fwhm) 
37 °C 
λ max (fwhm) 
Ppy WT 100 100 100 0.26 557 (66) 563, 610(sh) (92) 
  Ppy REa 23 18 32 0.80 615 (57) 616 (64) 
 Ppy RE-TS 31 15 61 8.8 610 (59) 612 (60) 
PRET7 22 21 34 >24 617 (60) 618 (62) 
CBR 3 3 4 2.1 617 (62) 619 (66) 
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Heat inactivation studies. In addition to enzyme color, specific activity, and 
kinetics, thermostability at 37°C was another property of PRET7 that was analyzed.  
In vivo expression of luciferases requires enzymes that remain stable at physiological 
temperature, approximately 37°C. While in vitro reporter assays can be carried out at any 
controlled temperature, the expression that is monitored often takes place at 37°C, and 
should be assayed at this temperature to serve an accurate reporter function. For both  
in vivo and in vitro experiments, it is predicted that luciferases with greater stability at 
37°C are more likely to be expressed as properly-folded proteins in higher yield, and will 
remain active for longer time periods, resulting in more sensitive reporter assays overall.  
Ppy RE-TS was much more stable at 37°C than its template Ppy RE, retaining at 
least 50% activity for up to 8.8 hours at 37°C, compared to 0.8 hours, and it was 
anticipated that PRET7 would share this characteristic (Table 1). The PRET7 inactivation 
assay results surpassed expectations, since PRET7 did not drop below 50% activity even 
after 24 hours of incubation. It is uncertain whether the outstanding thermostability of 
PRET7 will translate to a significant advantage in reporter assays compared to  
Ppy RE-TS or CBR, since it is possible that a 24 hour period of stability is far greater 
than is necessary for a sensitive assay. But in theory, PRET7 should be a generally more 
versatile enzyme to work with at room temperature and physiological temperature, since 
refrigeration is less imperative. The possibility of protein degradation due to heat-
exposure, which might be a problem for some researchers (26), will be avoided if PRET7 
is used. 
Microplate luminometer studies. To compare the performances of PRET7 and 
CBR, 8-second plots of light-emission were generated and integrated for pure proteins, 
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bacterial cell lysates, and HEK293 mammalian cells using 96-well microplate 
luminometers (Figs. 5-7, Table 2). These studies were carried out with both minimal 
assay reagents (MAR) and Promega’s Luciferase Assay Reagent (LAR), so as to assess 
the feasibility of using these reagents for reporter assays with these enzymes.  
Minimal assay reagents include the bare minimum of substrates required for the 
reaction, LH2 and Mg-ATP, as well as 25mM glycylglycine buffer at pH 7.8. The 
performance of PRET7 in minimal assay reagents was superior to CBR under all three 
assayed conditions. The intrinsic properties of the PRET7 protein resulted in 6-fold 
greater activity than CBR (Fig. 5, Table 2). However, in bacterial cell lysates the 
advantage dropped to 3.5-fold, and in mammalian cells it dropped to 2.5-fold, suggesting 
that CBR is expressed in higher yield in these cells lines compared to PRET7 (Figs. 6 and 
7). It was expected that CBR, because it is human-codon optimized, would be expressed 
more efficiently in mammalian cells than bacterial cells, which may explain the 
difference between the 3.5-fold and 2.5-fold advantages. But it is unclear why CBR 
expression is better than that of PRET7 in E. Coli at 37°C, considering the 
thermostability exhibited by PRET7 at that temperature. It is possible that the codon-
optimization of CBR for expression in human cell lines has favorable effects in bacterial 
cells as well. Regardless, when minimal assay reagents are used the specific activity of 
PRET7 is sufficiently high to outweigh disadvantages in the expression.     
When LAR was used, the superior performance of PRET7 over CBR was 
diminished in the pure protein assay, dropping to a 2-fold advantage (Fig. 5, Table 2). In 
bacterial and mammalian cell lysates, LAR assays actually favored CBR, which had a 
2.7-fold greater activity when expressed in bacteria and a 1.3-fold greater activity when 
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expressed in mammalian cells (Figs. 6 and 7, Table 2). According to the pure protein data, 
LAR appears to decrease PRET7 integrated activity, in part by dampening the initial flash, 
and also elicits a steady rise in light emission from CBR (Fig. 5). Because the full 
formula of LAR is proprietary, it is not possible to determine precisely how the enzyme 
kinetics and activity are affected biochemically.  It is likely that additional chemicals, 
such as coenzyme A (27), have been added to the minimal substrates, and it appears that 
these components favor Promega’s enzyme while impairing PRET7.  
Using two different reagents also affected the linear ranges of detection for these 
luciferases, but not dramatically (Fig. 8). In MAR, PRET7 provides a detectable signal 
when assayed at 3×10-18 mol quantities, whereas CBR is only detectable to 1×10-16 mol. 
In LAR, the detection limits for the two luciferases begin to converge, such that both 
enzymes reach their detection limit close to 1×10-17 mol, though PRET7 still appears to 
provide a slightly stronger signal at all assayed concentrations.  
In summary, the microplate luminometer assays indicate that PRET7, though it 
has lower expression levels in cell cultures than CBR, has comparatively impressive 
light-emission over an 8-second time period when minimal assay reagents are used. It is 
also detectable in lower quantities than CBR when assayed as a pure protein in MAR, 
which may translate to greater sensitivity in an applied bioluminescence assay system. 
Also promising is the finding that PRET7 performed best in MAR instead of the 
commercial reagent LAR. An enzyme like PRET7 that performs well with the simple, 
relatively inexpensive reagents Mg-ATP and LH2 may be appreciated by researchers who 
do not want to purchase entire assay kits.       
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Figure 5. Bioluminescence of pure red-emitting luciferases reacted with A) minimal assay reagent (MAR) and B) 
Luciferase Assay Reagent (LAR). Relative light emission of PRET7 (red curve) and CBR (blue curve) was 
measured in a Luminoskan Ascent Microplate Luminometer. Assays (0.262 ml) were performed in triplicate at pH 
7.8 and ambient temperature as described in Materials and Methods, and mean values were plotted. 
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Figure 6. Bioluminescence of soluble cell lysates from E. Coli which expressed red-emitting GST-fusion luciferases 
PRET7 and CBR at 37°C. Cell lysates were reacted with A) minimal assay reagent (MAR) and B) Luciferase Assay 
Reagent (LAR). Relative light emission of PRET7 (red curve) and CBR (blue curve) was measured in a Luminoskan 
Ascent Microplate Luminometer using a 2s delay. Assays (0.262 ml) were performed in triplicate at pH 7.8 and 
ambient temperature, and mean values were plotted.  Plots differ in appearance because the LAR assay was performed 
with an additional luminometric measurement, as explained in Materials and Methods, that resulted in higher relative 
light unit values and a cleaner line.   
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Figure 7. Bioluminescence of soluble cell lysates from HEK293 cells which expressed red-emitting GST-fusion 
luciferases PRET7 and CBR at 37°C. Cell lysates were reacted with A) minimal assay reagent (MAR) and B) 
Luciferase Assay Reagent (LAR). Relative light emission of PRET7 (red curve) and CBR (blue curve) in pH 7.8 
buffer was measured with a Varioskan Flash plate reader with a built-in delay of 0.8s, as described in Materials 
and Methods. 
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aIntegrated values are reported in relative light units that are dependent on programming and instrumentation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Relationship of relative bioluminescence activity to enzyme concentration for purified red-
emitting luciferases in (A minimal assay reagent (MAR) and B) Luciferase Assay Reagent (LAR). 
Luciferase activity (relative emission intensity) of PRET7 (red line, R2 =0.99), and CBR (blue line,  
R2 =0.99) were measured in a Luminoskan Microplate Luminometer. Activity assays (0.262 ml) were 
performed in triplicate at pH 7.8 and ambient temperature as described in Materials and methods. The 
mean values are plotted. 
 
   
Table 2.  Integrated relative luminescence of luciferase proteinsa 
Enzyme pure protein (Fig. 5) bacterial soluble cell extract (Fig. 6) mammalian soluble cell extract (Fig. 7) 
 MAR LAR MAR LAR MAR LAR 
PRET7 397 229 176 6933 9 494 047 192 945 440 
CBR 63 101 48 18706 3 954 664 254 490 861 
 
A.  MAR 
 
B.  LAR 
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Codon-optimization for mammalian cells. Though PRET7 performance in 
minimal reagents was superior to CBR even in mammalian cells, we anticipate that 
human-codon optimization of PRET7 will lead to further improvements. The PRET7 
gene has just recently been codon-optimized by collaborators Amit P. Jathoul and Martin 
A. Pule (University College London). To tailor the enzyme for mammalian cell 
expression, silent mutations were made throughout the DNA sequence to favor the codon 
usage bias of human cells, rather than firefly cells. The sequence was also altered to 
eliminate stretches of G and C repeats, local hairpins, and cryptic splice sites, and to 
remove the C-terminal targeting sequence that directs peroxisomal degradation. 
Additionally, the GC content was increased to 70%, a strategy known to increase the 
efficiency of expression (28). With optimized sequence, we presume that more properly-
folded protein will remain in the cytosol for a greater length of time, increasing the 
overall light-emission (29). Aside from Promega’s CBR, luciferases from Renilla, P. 
Pyralis, and Gaussia fireflies have been codon-optimized for mammalian cells with 
success (30, 31, 32). 
 The PRET7 human codon-optimized plasmid has been sent to Promega 
collaborators for reevaluation in mammalian cells, and will again be compared to CBR. It 
is anticipated that codon-optimizing PRET7 will improve the 2.5-fold advantage that was 
observed relative to CBR. The 6-fold advantage observed in the pure protein assays 
represents the maximum value that would be achieved if the proteins were expressed in 
equal quantities. The end result will be a red-emitting enzyme that, when compared with 
a marketed enzyme, has near-identical color, at least 10 times more longevity at 37°C, 
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and emits a stronger bioluminescent signal in bacterial and mammalian cells lysates when 
assayed with the least expensive reagents. We look forward to receiving in vivo imaging 
results from collaborators in Bologna, Italy to conclusively determine whether PRET7 is 
a viable candidate for imaging studies, as well.   
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